Lawsuit Information Center Blog

Last week I read speculation that the Roundup lawsuits might bankrupt Bayer because the cost of the settlements and verdicts they will have to pay will destroy the company.  Do I believe this?  No.  But, boy, it makes me more interested in every tidbit of information about the Roundup lawsuits pending in federal court.

The judge overseeing all of the federal lawsuits involving the weed killer Roundup has granted Bayer’s request to have an upcoming trial split into two phases. This order prevents plaintiffs from introducing evidence that the company tried to influence regulators and manipulate the public into thinking that glyphosate, the active ingredient in Roundup, was safe. Roundup plaintiffs’ attorneys opposed Bayer’s proposals because they felt that their evidence proves Monsanto’s intent and misconduct.

Upcoming trial in February 2019

In July 2018, 3M settled a lawsuit with the federal government over its Combat Arms Earplugs, Version 2 (CAEv2), which it had sold to the US military. The lawsuit alleged that 3M knowingly supplied them with defective earplugs that may have resulted in the hearing loss and impairment of hundreds of thousands of military personnel.  Does this mean 3M did certainly did something wrong?  No.  But where there is smoke there is usually fire.

I do not think this is going to be the last Combat Arms Earplug lawsuit that 3M is going to have to settle.

Combat Arms Earplugs, Version 2

I’m writing to update you on the Taxotere class action (MDL) lawsuits.

Taxotere is a chemotherapy drug used to treat a number of cancers, especially breast cancer. Taxotere is a taxanes.  Taxanes are diterpenes produced by the plants of the genus Taxus that have a taxadiene core. Taxanes are widely used as chemotherapy agents.

Taxotere has been one of the most widely used chemotherapy drugs since it was developed in the mid-1990s. Chemotherapy drugs like Taxotere work by attacking cancer cells within the body. Taxotere was originally developed and introduced by the New Jersey pharmaceutical company Adventis which is now Sanfoi-Adventis.

As I have been saying, the Zostavax vaccine lawsuits are jumping with energy right now.  Lawyers want these cases which is why you see television commercials and Facebook and Google ads (and, yes, legal blog posts) from attorneys hustling to sign up victims.

These Zostavax lawsuits allege that the plaintiffs experienced severe complications, most notably shingles, from being administered it. Another lawsuit has recently been filed in the Pennsylvania courts, that allege even more side effects other than shingles or Bell’s palsy.

Georgia woman gets bronchitis from Zostavax

U.S. District Judge Vince Chhabria will preside hold the first glyphosate cancer case in federal court on February 25, 2019. It will be the first of over 600 cases that are in federal litigation to go to trial.

First Federal Trial Involving Roundup

This lawsuit involves a California man who claims that his long-term exposure to Roundup resulted in him receiving large B-cell non-Hodgkins lymphoma. His exposure stems from using Roundup to control poison oak and weed growth on his property since the 1980s. The complaint was filed in February 2016, about one year after his cancer diagnosis in 2015. The lawsuit alleges that the Monsanto, Roundup’s manufacturer, failed to exercise with care with respect to testing, manufacturing, and marketing it. It also alleges that Monsanto was being deceptive by claiming that Roundup was as safe as table salt.